SANDER A FLAUM Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SANDER A FLAUM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SANDER A FLAUM. SANDER A FLAUM is Director in ATRIX LABORATORIES INC ($ATRX) and Director in EAGLE PHARMACEUTICALS, INC. ($EGRX).
Latest Insider Trading Transactions of SANDER A FLAUM
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 06 2019 | EGRX | EAGLE PHARMACEUTIC ... | FLAUM SANDER A | Director | Option Exercise | M | 4.04 | 2,340 | 9,454 | 0 | |
Mar 06 2019 | EGRX | EAGLE PHARMACEUTIC ... | FLAUM SANDER A | Director | Payment of Exercise | F | 48.89 | 204 | 9,974 | 13,510 | 13.7 K to 13.5 K (-1.49 %) |
Mar 06 2019 | EGRX | EAGLE PHARMACEUTIC ... | FLAUM SANDER A | Director | Buy | M | 4.04 | 2,340 | 9,454 | 13,714 | 11.4 K to 13.7 K (+20.57 %) |
Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | FLAUM SANDER A | Director | Option Exercise | A | 42.40 | 10,000 | 424,000 | 10,000 | |
Mar 07 2018 | EGRX | EAGLE PHARMACEUTIC ... | FLAUM SANDER A | Director | Option Exercise | M | 0.90 | 2,340 | 2,106 | 0 | |
Mar 07 2018 | EGRX | EAGLE PHARMACEUTIC ... | FLAUM SANDER A | Director | Sell | S | 53.94 | 2,340 | 126,220 | 11,374 | 13.7 K to 11.4 K (-17.06 %) |
Mar 07 2018 | EGRX | EAGLE PHARMACEUTIC ... | FLAUM SANDER A | Director | Buy | M | 0.90 | 2,340 | 2,106 | 13,714 | 11.4 K to 13.7 K (+20.57 %) |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | FLAUM SANDER A | Director | Option Exercise | A | 59.14 | 10,000 | 591,400 | 10,000 | |
Jan 06 2017 | EGRX | EAGLE PHARMACEUTIC ... | FLAUM SANDER A | Director | Option Exercise | A | 84.92 | 10,000 | 849,200 | 10,000 | |
Nov 30 2016 | EGRX | EAGLE PHARMACEUTIC ... | FLAUM SANDER A | Director | Sell | S | 78.66 | 5,000 | 393,300 | 11,374 | 16.4 K to 11.4 K (-30.54 %) |
Jan 05 2016 | EGRX | EAGLE PHARMACEUTIC ... | FLAUM SANDER A | Director | Option Exercise | A | 86.15 | 15,000 | 1,292,250 | 15,000 | |
Dec 23 2015 | EGRX | EAGLE PHARMACEUTIC ... | FLAUM SANDER A | Director | Sell | S | 93.76 | 3,225 | 302,360 | 16,374 | 19.6 K to 16.4 K (-16.45 %) |
Dec 23 2015 | EGRX | EAGLE PHARMACEUTIC ... | FLAUM SANDER A | Director | Sell | S | 42.00 | 9,800 | 411,600 | 19,599 | 29.4 K to 19.6 K (-33.33 %) |
Apr 22 2015 | EGRX | EAGLE PHARMACEUTIC ... | FLAUM SANDER A | Director | Option Exercise | A | 59.31 | 10,000 | 593,100 | 10,000 | |
Mar 17 2015 | EGRX | EAGLE PHARMACEUTIC ... | FLAUM SANDER A | Director | Option Exercise | A | 46.09 | 5,000 | 230,450 | 5,000 | |
Sep 29 2003 | ATRX | ATRIX LABORATORIES ... | FLAUM SANDER A | Director | Grant | A | 21.85 | 80 | 1,748 | 4,174 | 4.1 K to 4.2 K (+1.95 %) |
Page: 1